ArticleJournal of the National Cancer Institute2022

Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.

Cristina P Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.